Recent News

• 03.11.2025 - Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
• 03.06.2025 - Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024
• 02.24.2025 - Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025
• 01.07.2025 - Stevanato Group to Present at Upcoming Investor Conference
• 11.11.2024 - Stevanato Group to Present at Upcoming Investor Conferences

Recent Filings

• 03.06.2025 - EX-99.1 EX-99.1
• 03.06.2025 - EX-99.1 EX-99.1
• 03.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.06.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.10.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.17.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.10.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2024 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors